Interestingly, SPP1+ macrophages have been described in numerous diseases, such as fatty liver (43), COVID-19 (44), dystrophic muscle (45), and cancers (46), indicating a conserved functional phenotype across diseases. This evidence concerns the gene SPP1 and COVID-19.